Australian study shows Phytodolor could save $178 million in healthcare costs each year |
| Sep 13 2010 |
An economic study into the cost effectiveness of complementary medicines in Australia has identified potential savings of $178 million each year if Phytodolor was used in place of non steroidal anti-inflammatory drugs (NSAIDs) for the treatment of osteoarthritis.
To see press release click here
To see Sydney Morning Herald article, 13th September 2010 click here
Back